Publisher
Springer International Publishing
Reference13 articles.
1. Calis KA, Archdeacon P, Bain RP, Forrest A, Perlmutter J, DeMets DL. Understanding the functions and operations of data monitoring committees: Survey and focus group findings. Clin Trials. 2017;14(1):59–66.
2. Fleming TR, DeMets DL, Roe MT, Wittes J, Calis KA, Vora AN, Meisel A, Bain RP, Konstam MA, Pencina MJ, Gordon DJ, Mahaffey KW, Hennekens CH, Neaton JD, Pearson GD, Andersson TLG, Pfeffer MA, Ellenberg SS. Data Monitoring Committee: promoting best practices to address emerging challenges. Clin Trials. 2017;14(2):115–23.
3. Levinson DR. Data safety and monitoring boards in NIH clinical trials: meeting guidance, but facing some issues. Washington, DC: Department of Health and Human Services, Office of the Inspector General; 2013. (OEI-12-11-00070).
4. FDA. Guidance for clinical trial sponsors: establishment and operations of clinical trial monitoring committees. 2006.
www.fda.gov
. Accessed 28 Mar 2019.
5. Marston L, McKenzie DR, Freemantle N. Pursuit of truly independent data monitoring committees in research. BMJ. 2016;353:i2309.